Attached files

file filename
EX-99 - EXHIBIT 99.1 - ALTAIR NANOTECHNOLOGIES INCex99-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): November 13, 2013  

 

Altair Nanotechnologies Inc.

(Exact Name of Registrant as Specified in it's Charter)

 

 Delaware

 

 1-12497

 

 33-1084375

 (State or other jurisdiction of

incorporation or organization)

 

 (Commision

File Number)

 

 (IRS Employer

Identification No.)

 

204 Edison Way

Reno NV

 

 89502

(Address of Principal Executive Offices)

 

 (Zip Code)

 

 

 Registrant's Telephone Number, Including Area Code:

 

 

 (775) 856-2500

 

 

 N/A

(Former name, former address, and formal fiscal year, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

  

 
 

 

 

TABLE OF CONTENTS

       

 

Item 2.02 Results of Operations and Financial Condition
   

Item 9.01  

Exhibits

   

SIGNATURES

 
EXHIBIT INDEX
 

EX. 99.1

Press release entitled “Altair Nanotechnologies Reports Third Quarter 2013 Financial Results.”

   

 
2

 

 

Item 2.02  Results of Operations and Financial Condition.

 

On November 13, 2013, the Company issued a press release entitled “Altair Nanotechnologies Reports Third 2013 Financial Results.” The full text of the press release is provided here to as Exhibit 99.1 and is hereby incorporated by reference into this item 2.02.

 

The Company will hold a conference call to discuss its third quarter 2013 results on Wednesday, November 13, 2013 at 11:00 a.m. Eastern Daylight Time (EDT). Shareholders and members of the investment community are invited to participate in the conference call. The dial-in number for both U.S. and international callers is +1 678-224-7719. Please dial in to the conference five minutes before the call is scheduled to begin. Ask the operator for the Altair Nanotechnologies call.

 

Post call, a phone-based audio replay of the conference call will be available from 2:00 p.m. EDT, Wednesday November 13, 2013 until Midnight EDT, November 19, 2013. It can be accessed by dialing +1 404-537-3406 and entering conference number 98910043.

 

Additionally, the conference call and replay will be available online, and can be accessed by visiting Altairnano's web site, www.altairnano.com.

 

The information in this Item 2.02 of this Current Report on Form 8K (including the exhibits) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

 

Item 9.01 Financial Statements and Exhibits.

 

 

(d)

Exhibits.

 

 

99.1

Press Release issued by Altair Nanotechnologies Inc. dated November 13, 2013 entitled “Altair Nanotechnologies Reports Third Quarter 2013 Financial Results”

 

 
3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Altair Nanotechnologies Inc.

 

 

 

     
     

Dated: November 13, 2013

By

/s/ Paula Conroy     

 

 

Paula Conroy, Chief Financial Officer

 

 

 

 

4